Geode Capital Management
LSTA icon

Geode Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Geode Capital Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355K Buy
70,887
+6,459
+10% +$26.7K ﹤0.01% 3697
2025
Q4 		$120K Buy
64,428
+1,168
+2% +$2.6K ﹤0.01% 4052
2025
Q3 		$166K Buy
63,260
+2,178
+4% +$5.46K ﹤0.01% 3987
2025
Q2 		$176K Buy
61,082
+553
+0.9% +$1.33K ﹤0.01% 3915
2025
Q1 		$142K Buy
60,529
+4,634
+8% +$12.5K ﹤0.01% 3938
2024
Q4 		$167K Buy
55,895
+214
+0.4% +$612 ﹤0.01% 3958
2024
Q3 		$167K Buy
55,681
+4,783
+9% +$15.1K ﹤0.01% 3961
2024
Q2 		$177K Buy
50,898
+6,548
+15% +$19.9K ﹤0.01% 3958
2024
Q1 		$138K Buy
44,350
+960
+2% +$2.84K ﹤0.01% 4049
2023
Q4 		$118K Hold
43,390
– – ﹤0.01% 4127
2023
Q3 		$90.7K Buy
43,390
+17,417
+67% +$48.4K ﹤0.01% 4279
2023
Q2 		$96.1K Hold
25,973
– – ﹤0.01% 4346
2023
Q1 		$84.4K Hold
25,973
– – ﹤0.01% 4394
2022
Q4 		$64K Sell
25,973
-65
-0.2% -$238 ﹤0.01% 4525
2022
Q3 		$120K Sell
26,038
-4
-0% -$29 ﹤0.01% 4488
2022
Q2 		$207K Buy
26,042
+565
+2% +$4.65K ﹤0.01% 4242
2022
Q1 		$275K Hold
25,477
– – ﹤0.01% 4221
2021
Q4 		$321K Hold
25,477
– – ﹤0.01% 4267
2021
Q3 		$466K Buy
25,477
+642
+3% +$12.6K ﹤0.01% 4063
2021
Q2 		$599K Buy
24,835
+3,625
+17% +$85.9K ﹤0.01% 3855
2021
Q1 		$614K Buy
21,210
+18,107
+584% +$549K ﹤0.01% 3733
2020
Q4 		$66K Hold
3,103
– – ﹤0.01% 4122
2020
Q3 		$83K Hold
3,103
– – ﹤0.01% 3936
2020
Q2 		$82K Hold
3,103
– – ﹤0.01% 3901
2020
Q1 		$83K Hold
3,103
– – ﹤0.01% 3822
2019
Q4 		$116K Hold
3,103
– – ﹤0.01% 3951
2019
Q3 		$117K Hold
3,103
– – ﹤0.01% 3912
2019
Q2 		$106K Hold
3,103
– – ﹤0.01% 3949
2019
Q1 		$168K Hold
3,103
– – ﹤0.01% 3778
2018
Q4 		$165K Hold
3,103
– – ﹤0.01% 3728
2018
Q3 		$274K Hold
3,103
– – ﹤0.01% 3659
2018
Q2 		$301K Buy
3,103
+1,309
+73% +$92.3K ﹤0.01% 3602
2018
Q1 		$157K Hold
1,794
– – ﹤0.01% 3750
2017
Q4 		$94K Sell
1,794
-139
-7% -$6.98K ﹤0.01% 3833
2017
Q3 		$103K Hold
1,933
– – ﹤0.01% 3822
2017
Q2 		$134K Sell
1,933
-29
-1% -$2.05K ﹤0.01% 3780
2017
Q1 		$148K Buy
1,962
+3
+0.2% +$208 ﹤0.01% 3739
2016
Q4 		$83K Buy
1,959
+3
+0.2% +$172 ﹤0.01% 3824
2016
Q3 		$135K Buy
1,956
+1
+0.1% +$81 ﹤0.01% 3726
2016
Q2 		$173K Hold
1,955
– – ﹤0.01% 3636
2016
Q1 		$219 Sell
1,955
-1
-0.1% -$98 ﹤0.01% 3604
2015
Q4 		$316K Buy
1,956
+1
+0.1% +$184 ﹤0.01% 3482
2015
Q3 		$436K Buy
1,955
+92
+5% +$23.1K ﹤0.01% 3283
2015
Q2 		$522K Buy
1,863
+995
+115% +$370K ﹤0.01% 3171
2015
Q1 		$330K Buy
868
+41
+5% +$22.2K ﹤0.01% 3380
2014
Q4 		$467K Buy
827
+2
+0.2% +$1.36K ﹤0.01% 3227
2014
Q3 		$684K Buy
825
+12
+1% +$10.5K ﹤0.01% 3011
2014
Q2 		$794K Buy
813
+204
+33% +$198K ﹤0.01% 2930
2014
Q1 		$644K Buy
609
+15
+3% +$16.3K ﹤0.01% 3024
2013
Q4 		$608K Buy
594
+180
+43% +$178K ﹤0.01% 2985
2013
Q3 		$531K Buy
414
+21
+5% +$23.3K ﹤0.01% 2913
2013
Q2 		$327K Buy
+393
New +$345K ﹤0.01% 3059

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Geode Capital Management's LSTA Position: Q1 2026 in Review

Geode Capital Management increased its Lisata Therapeutics (LSTA) stake by 10% in Q1 2026, buying an estimated $26.7K and bringing the position to 70,887 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

Geode Capital Management first reported a position in LSTA in Q2 2013 and has held it in 52 quarters since. The position peaked at $794K in Q2 2014. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Geode Capital Management held 70,887 shares of Lisata Therapeutics worth $355K as of Q1 2026.
  • Geode Capital Management bought 6,459 Lisata Therapeutics shares in Q1 2026, an estimated $26.7K.
  • Lisata Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3697 holding.
  • Geode Capital Management first reported a position in Lisata Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Lisata Therapeutics position peaked at $794K in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.